ILMN vs. WAT, BRKR, BIO, AVTR, RVTY, BIO.B, ALNY, BAX, LH, and COO
Should you be buying Illumina stock or one of its competitors? The main competitors of Illumina include Waters (WAT), Bruker (BRKR), Bio-Rad Laboratories (BIO), Avantor (AVTR), Revvity (RVTY), Bio-Rad Laboratories (BIO.B), Alnylam Pharmaceuticals (ALNY), Baxter International (BAX), Laboratory Co. of America (LH), and Cooper Companies (COO).
Illumina (NASDAQ:ILMN) and Waters (NYSE:WAT) are both large-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, community ranking, earnings, risk, media sentiment, profitability, dividends, analyst recommendations and valuation.
Waters has a net margin of 20.75% compared to Illumina's net margin of -28.71%. Waters' return on equity of 66.59% beat Illumina's return on equity.
Illumina presently has a consensus price target of $164.65, indicating a potential upside of 48.24%. Waters has a consensus price target of $305.78, indicating a potential downside of 14.10%. Given Illumina's stronger consensus rating and higher probable upside, equities research analysts plainly believe Illumina is more favorable than Waters.
Waters has lower revenue, but higher earnings than Illumina. Illumina is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks.
In the previous week, Waters had 39 more articles in the media than Illumina. MarketBeat recorded 53 mentions for Waters and 14 mentions for Illumina. Illumina's average media sentiment score of 0.83 beat Waters' score of 0.06 indicating that Illumina is being referred to more favorably in the media.
89.4% of Illumina shares are owned by institutional investors. Comparatively, 94.0% of Waters shares are owned by institutional investors. 0.2% of Illumina shares are owned by company insiders. Comparatively, 0.8% of Waters shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Illumina received 650 more outperform votes than Waters when rated by MarketBeat users. Likewise, 65.71% of users gave Illumina an outperform vote while only 54.30% of users gave Waters an outperform vote.
Illumina has a beta of 1.2, suggesting that its stock price is 20% more volatile than the S&P 500. Comparatively, Waters has a beta of 0.98, suggesting that its stock price is 2% less volatile than the S&P 500.
Summary
Waters beats Illumina on 10 of the 18 factors compared between the two stocks.
Get Illumina News Delivered to You Automatically
Sign up to receive the latest news and ratings for ILMN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ILMN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Illumina Competitors List
Related Companies and Tools
